Latest Insider Transactions at Accenture PLC (ACN)
This section provides a real-time view of insider transactions for Accenture PLC (ACN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Accenture plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Accenture plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
137
+0.41%
|
$24,249
$177.73 P/Share
|
|
Apr 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80
+0.42%
|
$14,160
$177.73 P/Share
|
|
Apr 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
160
+0.13%
|
$28,320
$177.73 P/Share
|
|
Apr 01
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.98%
|
$525,000
$175.83 P/Share
|
|
Apr 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
2,343
-3.3%
|
$412,368
$176.06 P/Share
|
|
Apr 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
4,000
-1.56%
|
$700,000
$175.99 P/Share
|
|
Apr 01
2019
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,182
-16.23%
|
$1,081,850
$175.65 P/Share
|
|
Mar 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.07%
|
$4,890
$163.22 P/Share
|
|
Mar 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125
+0.62%
|
$20,375
$163.22 P/Share
|
|
Mar 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.63%
|
$16,300
$163.22 P/Share
|
|
Mar 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
161
+0.56%
|
$26,243
$163.22 P/Share
|
|
Mar 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
153
+0.12%
|
$24,939
$163.22 P/Share
|
|
Mar 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.47%
|
$16,300
$163.22 P/Share
|
|
Mar 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
149
+0.42%
|
$24,287
$163.22 P/Share
|
|
Mar 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.46%
|
$14,181
$163.22 P/Share
|
|
Mar 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
174
+0.14%
|
$28,362
$163.22 P/Share
|
|
Mar 01
2019
|
David Rowland Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
13,706
+26.46%
|
-
|
|
Feb 11
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Indirect |
1,000
-90.0%
|
$156,000
$156.08 P/Share
|
|
Feb 11
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
1,000
-0.38%
|
$156,000
$156.08 P/Share
|
|
Feb 07
2019
|
Jaime Ardila Director |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-3.15%
|
$61,535
$155.09 P/Share
|
|
Feb 07
2019
|
Herbert Hainer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-13.88%
|
$143,995
$155.09 P/Share
|
|
Feb 07
2019
|
Marjorie Magner Director |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-2.75%
|
$73,160
$155.09 P/Share
|
|
Feb 07
2019
|
Nancy Mc Kinstry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
821
-15.34%
|
$127,255
$155.09 P/Share
|
|
Feb 07
2019
|
Gilles Pelisson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-10.13%
|
$143,995
$155.09 P/Share
|
|
Feb 07
2019
|
Paula A Price Director |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-6.04%
|
$73,160
$155.09 P/Share
|
|
Feb 07
2019
|
Arun Sarin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-7.93%
|
$73,160
$155.09 P/Share
|
|
Feb 07
2019
|
Frank Kui Tang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-11.66%
|
$175,460
$155.09 P/Share
|
|
Feb 07
2019
|
Tracey Thomas Travis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
611
-13.98%
|
$94,705
$155.09 P/Share
|
|
Feb 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.08%
|
$4,836
$156.98 P/Share
|
|
Feb 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
129
+0.65%
|
$20,124
$156.98 P/Share
|
|
Feb 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
103
+0.65%
|
$16,068
$156.98 P/Share
|
|
Feb 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
167
+0.58%
|
$26,052
$156.98 P/Share
|
|
Feb 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.12%
|
$24,180
$156.98 P/Share
|
|
Feb 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.3%
|
$9,828
$156.98 P/Share
|
|
Feb 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.43%
|
$24,180
$156.98 P/Share
|
|
Feb 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90
+0.47%
|
$14,040
$156.98 P/Share
|
|
Feb 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
180
+0.14%
|
$28,080
$156.98 P/Share
|
|
Feb 01
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
838
-2.01%
|
$129,052
$154.44 P/Share
|
|
Feb 01
2019
|
Jaime Ardila Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,233
+15.05%
|
-
|
|
Feb 01
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-3.22%
|
$100,716
$154.44 P/Share
|
|
Feb 01
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,712
+32.34%
|
-
|
|
Feb 01
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
699
-0.9%
|
$107,646
$154.44 P/Share
|
|
Feb 01
2019
|
Herbert Hainer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+24.19%
|
-
|
|
Feb 01
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-5.38%
|
$247,478
$154.44 P/Share
|
|
Feb 01
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
2,512
-1.87%
|
$386,848
$154.44 P/Share
|
|
Feb 01
2019
|
Marjorie Magner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,654
+13.37%
|
-
|
|
Feb 01
2019
|
Kathleen R Mc Clure Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.69%
|
$22,484
$154.44 P/Share
|
|
Feb 01
2019
|
Nancy Mc Kinstry Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,780
+24.96%
|
-
|
|
Feb 01
2019
|
Gilles Pelisson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+18.89%
|
-
|
|
Feb 01
2019
|
Paula A Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+14.8%
|
-
|